Drawing for AVIO

USPTO serial 97683493

AVIO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PORTARO, ALEXANDRA J
Law office
TMO LAW OFFICE 126

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AVIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matt Kulseth

Matt Kulseth KULSETH LAW P.L.L.C DBA MIGHTY MARKS4765 WATERTOWN RDORONO, MN 55359United States

Goods and services

ClassDescriptionStatusFirst use
035Business management consulting services, specifically federal and state regulatory guidance in the field of medical devices, pharmaceuticals and the life sciences; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Regulatory submission management, namely, assisting others in preparing and filing applications for medical devices and phamaceuticals with governmental regulatory bodiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 29, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 29, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 15, 2024RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
May 15, 2024RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
May 15, 2024RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Apr 15, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 15, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 15, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 13, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 13, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 13, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2023DOCKASSIGNED TO EXAMINER—
Dec 9, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 22, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance